PRCM
AGN.PRA

Pine River Capital Management’s Allergan plc AGN.PRA Stock Holding History

Pine River Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-85,000
Closed -$87.2M – 844
2015
Q4 		$87.2M Hold
85,000
– – 1.16% 13
2015
Q3 		$80.3M Buy
+85,000
New +$88.7M 1.03% 14
2015
Q2 		– Hold
0
– – – 22

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Pine River Capital Management's AGN.PRA Position: Q1 2016 in Review

Pine River Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2016, closing a stake of 85,000 shares — an estimated $87.2M sold.

Pine River Capital Management first reported a position in AGN.PRA in Q3 2015 and held it in 2 quarters. The position peaked at $87.2M in Q4 2015. 103 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2016.

  • Pine River Capital Management reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Pine River Capital Management sold 85,000 Allergan plc shares in Q1 2016, an estimated $87.2M.
  • Pine River Capital Management first reported a position in Allergan plc in Q3 2015 and held it in 2 quarters.
  • Pine River Capital Management's Allergan plc position peaked at $87.2M in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.